Headache & Pain

Filter Your Results




Study Confirms Benefits of Laser Interstitial Thermal Therapy

Wednesday, November 14, 2018—A prospective, multi-center clinical study of 42 patients with brain lesions that recurred after stereotactic radiosurgery (SRS) for metastatic brain tumors showed p…

Personal Pain Management App Approved for Use with Intrathecal Drug Delivery Pump

Wednesday, October 24, 2018—The US Food and Drug Administration (FDA) has approved use of an application (myPTM Personal Therapy Manager; Medtronic, Dublin, Ireland) for patients with chronic pain to use…

First Patient Treated in Trial of BHV-3500—A Nasally Delivered CGRP-Receptor Antagonist Being Investigated for Migraine

Tuesday, October 23, 2018—The first participant has been treated in a clinical trial of BHV-3500 (Biohaven, New Haven, CT) for the treatment of patients with migraine. The first intranasal formulation …

Medtronic Launches Control Workflow—An Evidence-Based Protocol for Use With Intrathecal Drug Delivery Pump for Effective Pain Relief

Friday, October 19, 2018—The Control Workflow system (Medtronic, Dublin, Ireland) is an evidence-based approach for use with the intrathecal drug delivery pump (SynchroMed II; Medtronic) to assist phy…

Safety Confirmed for Ubrogepant—A Small-Molecule Oral CGRP Receptor Antagonist for Treatment of Acute Migraine

Wednesday, October 17, 2018—Safety and tolerability studies have been completed for ubrogepant (Allergan, Dublin, Ireland) in patients with acute migraine over 1 year (NCT2867709) and in healthy voluntee…

FDA Approves Galcanezumab for Prevention of Migraine

Friday, September 28, 2018—The Food and Drug Administration (FDA) has approved galcanezumab-glnm (Emgality; Lilly, Indianapolis, IN) for the prevention of migraine in adults. Galcanezumab is available a…

Fremanezumab-vfrm Approved for Prevention of Migraine

Monday, September 17, 2018—The Food and Drug Administration (FDA) has approved fremanezumab-vfrm (Ajovy; Teva Pharmaceutical Industries, Jerusalem, Israel) for prevention of migraine in adults. Fre…

New Investigational Intranasal CGRP-Antagonist for Treatment of Migraine

Wednesday, September 12, 2018—An investigational drug application has been filed with the Food and Drug Administration (FDA) for BHV-3500 (Biohaven, New Haven, CT). This new compound is the first intranasa…


Contact Info

For advertising rates and opportunities:
Wendy Terry

About Practical Neurology

Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.